Production (Stage)
Generation Bio Co.
GBIO
$0.3691
-$0.0139-3.63%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 57.45% | -3.99% | -17.48% | -24.87% | -26.41% |
| Total Depreciation and Amortization | -9.34% | -6.31% | -3.86% | -3.03% | -0.34% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -81.05% | 361.96% | 308.43% | 270.74% | 166.08% |
| Change in Net Operating Assets | -183.08% | -158.71% | -149.07% | -132.91% | 389.84% |
| Cash from Operations | -50.14% | -67.91% | -92.55% | -122.45% | 40.05% |
| Capital Expenditure | 91.48% | 67.54% | -88.71% | -101.19% | -26.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2,410.62% | 4,304.00% | 226.91% | -14.66% | 102.08% |
| Cash from Investing | 2,215.19% | 1,074.73% | 185.30% | -38.89% | 97.63% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -20.15% | -98.81% | -98.75% | -99.04% | -98.90% |
| Repurchase of Common Stock | 86.15% | 67.08% | 54.49% | 55.01% | 37.05% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 108.38% | 108.38% | -365.52% |
| Cash from Financing | 560.00% | -99.30% | -99.49% | -99.88% | -100.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 121.44% | 123.35% | -82.95% | -802.68% | 74.52% |